Key facts
- Upheal’s last known valuation is $48.5M.
- It has raised $14.3M; the latest was Early Stage VC ($10.0M) in Nov 2024.
- Notable investors include Headline, Inovia Capital, Calm/Storm Ventures, Credo Ventures, Kaya VC — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Upheal
- ·The full record, as it builds
Funding rounds
No funding rounds for Upheal are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Upheal
Developer of an artificial intelligence-based platform designed for mental health professionals with automated notes and analytics. The company's platform is a therapy tool with secure video calling, automated progress notes, and analytics built in, captures the session in the background, and creates DAP-informed progress notes, which can be easily edited during the call or after, enabling mental health professionals to get pre-identified and organize insights without missing any details.
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Founded
- 2021
- Employees
- 13
- Website
- upheal.io/
- Ownership
- Privately Held (backing)
Upheal doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Upheal shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Upheal in its N-PORT filings yet. We sweep new filings monthly.